Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Deciphering Heterogeneity: The Good, The Bad and The Different

Four online seminars launched by the University of Arizona College of Pharmacy are aimed at helping health care decision-makers understand how heterogeneity, or individual treatment effects, impact patient health outcomes.

The seminars are particularly relevant given the growing interest in comparative effectiveness research (CER), which can be very useful in helping patients and their health care providers make informed decisions about their treatment options. The challenge, however, is in figuring out whether the information will apply to an individual patient who might respond differently to that treatment. That’s because most CER studies examine how an “average” patient will respond to a treatment, leaving some patients wondering about whether CER findings will apply to them.

To address these concerns, the seminars explain how to evaluate CER findings for heterogeneity, the implications of applying “average” effects to individual patients or groups, and how heterogeneity influences patient outcomes. The seminars are geared toward medical and pharmacy directors, pharmacy managers, clinical support pharmacists, and clinicians.

The presentations include:

The seminars were developed by the Comparative Effectiveness Research Group at the University of Arizona College of Pharmacy with funding from the National Pharmaceutical Council.

In addition to the four seminars, the University of Arizona College of Pharmacy CER Group website features other heterogeneity tools and resources. These materials include two downloadable checklists, one to assess heterogeneity within a study, and another to assess heterogeneity across different studies, along with links to related websites and videos.

Blog Post

Optimizing the recipe for ‘health care spending pie’: Finding the most effective resource allocation

As health care costs continue to climb, rising 5.3 percent in 2015 and approaching 18 percent of the U.S. economy, it is more essential than ever to...
Blog Post

Are We Getting the Right Data to Make Individualized Health Decisions? Maybe.

Personalized medicine—an evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each...
Blog Post

CER Tweets of the Week: AHCJ CER Fellowships Announced; Latest Issue of JCER Published (August 8-12)

Last week, comparative effectiveness research stakeholders tweeted about the announcement of this year’s Association of Health Care Journalists CER...
Blog Post

CER Tweets of the Week: EBM in Elite Sports; Clinical Nuances (August 1 – August 5)

Last week, comparative effectiveness research stakeholders tweeted about a blog post published in BMJ (@BJSM_BMJ) that discusses the use of evidence...
Press Release

Data Can Offer Critical Insights, But Roadblocks to Data Access Persist

(Washington, D.C., April 1, 2016)—Data is key to improving health outcomes and creating efficiencies in our health care system, but a new study...
Press Release

Fit for Purpose? New NPC, AcademyHealth Framework Closes Gaps Between Payer Needs and Research Answers

(Washington, DC, September 21, 2015)—Despite multi-million dollar public and private investments to tap into big data and improve the evidence...
Press Release

NPC Comments on CMS’ Announcement to Allow Broader Access to Publicly Funded Databases

(Washington, DC, June 2, 2015)—The National Pharmaceutical Council (NPC) today commented on the Centers for Medicare and Medicaid Services’ (CMS)...
Press Release

State Medicaid Directors Share Views on Comparative Effectiveness Research And Its Impact on Policy in National Pharmaceutical Council Survey

(Washington, DC, April 16, 2015)—A new survey conducted on behalf of the National Pharmaceutical Council (NPC) shows that state Medicaid directors...
Commentary and Testimony Page

The Importance of Evidence, Value, Access and Innovation in 2016

Last year, in our 2015 Health Care Outlook published in Chain Drug Review, I highlighted the recent announcement by the U.S. Department of Health and...
Commentary and Testimony Page

Chain Drug Review – Commentary: “Health Care Outlook for 2015”

This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
YouTube Videos

2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

This one-hour webinar highlights the results of NPC's annual survey of comparative effectiveness research (CER) stakeholders and includes a panel...
YouTube Videos

When Is Evidence Fit for Purpose? Closing Gaps Between Researchers, Payers

Despite multi-million dollar public and private investments to tap into big data and improve the evidence available for health care decision-making,...
YouTube Videos

Comparative Effectiveness Research and the Environment for Health Care Decision-Making

During a March 26, 2015 webinar, the National Pharmaceutical Council discussed the results of its annual stakeholder survey on comparative...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

Optimizing the recipe for ‘health care spending pie’: Finding the most effective resource allocation

As health care costs continue to climb, rising 5.3 percent in 2015 and approaching 18 percent of the U.S. economy, it is more essential than ever to...
Blog Post

Are We Getting the Right Data to Make Individualized Health Decisions? Maybe.

Personalized medicine—an evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each...
Blog Post

CER Tweets of the Week: AHCJ CER Fellowships Announced; Latest Issue of JCER Published (August 8-12)

Last week, comparative effectiveness research stakeholders tweeted about the announcement of this year’s Association of Health Care Journalists CER...
Blog Post

CER Tweets of the Week: EBM in Elite Sports; Clinical Nuances (August 1 – August 5)

Last week, comparative effectiveness research stakeholders tweeted about a blog post published in BMJ (@BJSM_BMJ) that discusses the use of evidence...

Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges

This study provides an early evaluation of the CER Collaborative's training program's impact on...

Data, Data Everywhere, But Access Remains a Big Issue for Researchers

This study captures the policy inconsistencies and hurdles that can hinder use of publicly funded...
cersurvey16

2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making

NPC's sixth annual survey of stakeholder views on comparative effectiveness research (CER) and the...
  •  
  • 1 of 16
  • >